Growing Need In For The Development Of More Sensitive HIV Diagnostic Point Of Care Tests Is Expected To Drive EEG Devices Market Growth Till 2025: Grand View Research,Inc.
Global HIV Diagnostics Market is expected to reach USD 4.48 billion
by 2022, growing at an estimated CAGR of 9.5% from 2015 to 2022, according to a
new study by Grand View Research, Inc. Key factors accounting for the growth of
this market include the growing need in for the development of more sensitive
HIV diagnostic point of care tests which can be easily implemented at the
location of patient care in resource limited settings.
Technological
development of tests which is expected to introduce a number of novel rapid,
point-of-care tests throughout the forecast period is a primary factor expected
to fuel the growth of the HIV diagnostics market. Furthermore, government
programs and campaigns initiated against HIV, global healthcare efforts to
reduce disease incidence, and the presence of high unmet demand in the Middle
Eastern and Eastern regions of the market are some key factors expected to
serve as lucrative future growth opportunities.
Browse full research report on Hiv Diagnostics Market: http://www.grandviewresearch.com/industry-analysis/hiv-diagnostics-market
Further key findings from the study suggest:
- Antibody HIV diagnostic tests accounted for the
largest share of the market in 2014. This large share can be accounted for
by the high market usage and penetration rates of these tests which
include, ELISA, home access dried blood spot, western blot testing IFA and
RIPA. These tests are highly sensitive and accurate and thus are
most commonly used for screening and confirmation of HIV-1 & HIV-2.
- Viral Load testing and CD4 testing also accounted for
a considerable share of the market in 2014. There is a prevalent in the
market for the development of these tests which will make them more
sensitive, rapid in nature and portable to the point of care to enhance
their market usability and accessibility in resource limited HIV affected
regions.
- It is expected that during the forecast period a
number of novel point of care HIV diagnostic products will be
commercialized which are currently under clinical development and in
product pipelines of key market players. This increase in the range of
products s expected to fuel the growth of this market over the forecast
period.
- North America was observed to account for the largest
share of the market in 2014, which can be attributed to the presence of a
strong healthcare R&D scenario in which the presence of government
funding and ongoing corporate efforts to enhance product portfolio are
anticipated to accelerate the timelines for new product development. Furthermore,
the presence of favorable reimbursements policies for HIV and other
infectious diseases is also a factor accounting for this region’s large
share.
- Asia Pacific is expected to grow at a relatively
faster rate over the forecast period owing to, the presence of high levels
of unmet market demand for HIV screening and testing. Moreover,
collaborations among market participants from the western regions is
another significant expected to boost the growth of Asia Pacific HIV
diagnostics market during the forecast period.
- Key players of the market include Janssen
Diagnostics, Daktari Diagnostics, Cepheid, Hologic and Chembio Diagnostic
Systmes Inc.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
For the purpose of this study, Grand View Research has
segmented the HIV diagnostics market on the basis of product and region:
HIV Diagnostics Product Outlook (Revenue, USD Million,
2012 - 2022)
- Antibody
Tests
- HIV-1
Screening Tests
- ELISA/EIA
- Home
Access Dried Blood Spot
- Rapid
Tests (Dot plot, Agglutination Tests)
- HIV-1
Antibody Confirmatory Tests
- Western
Blot Test
- Indirect
Immunofluorescent Antibody Assay (IFA)
- Line
Immunoassay
- RadioImmunoPrecipitation
Assay (RIPA)
- HIV-2
& Group O Diagnostic Tests
- Blood
Antibody Tests
- Dried
Blood Spot (DBS) Test
- Others
and (Oral, Urine)
- Viral
Identification Assays
- P24
Antigen Test
- Qualitative
PCR Tests
- Viral
Culture
- CD4
Testing
- Viral
Load Testing
- Early
Infant Diagnostics
HIV Diagnostics Regional Outlook (Revenue, USD Million,
2012 - 2022)
- North
America
- U.S.
- U.S.
HIV Diagnostics Market, by Product
- Canada
- Canada
HIV Diagnostics Market, by Product
- Europe
- Germany
- Germany
HIV Diagnostics Market, by Product
- UK
- UK
HIV Diagnostics Market, by Product
- Asia
Pacific
- Japan
- Japan
HIV Diagnostics Market, by Product
- China
- China
HIV Diagnostics Market, by Product
- Latin
America
- Brazil
- Brazil
HIV Diagnostics Market, by Product
- MEA
- South
Africa
- South
Africa HIV Diagnostics Market, by Product
Access Press Release
By Grand View Research: http://www.grandviewresearch.com/press-release/global-hiv-diagnostics-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment